BioPharma Credit PLC provided dividend guidance for the full year ending December 31, 2023. For the period, the company's target dividend of 7 cents per annum (December 31, 2022: 7 cents per annum).
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.876 USD | -0.23% | +0.40% | +4.70% |
Apr. 24 | BioPharma Credit, Unit to Loan up to $100 Million Each to US-based Tarsus Pharmaceuticals | MT |
Apr. 24 | BioPharma Credit to loan USD100 million to Tarsus Pharmaceuticals | AN |
1st Jan change | Capi. | |
---|---|---|
+4.70% | 1.08B | |
+3.74% | 12.61B | |
+6.68% | 9.01B | |
-3.20% | 5.41B | |
+2.44% | 5.25B | |
+5.63% | 5.19B | |
+14.36% | 4.48B | |
+16.67% | 4.44B | |
+1.53% | 4B | |
+1.83% | 3.75B |
- Stock Market
- Equities
- BPCP Stock
- News BioPharma Credit PLC
- BioPharma Credit PLC Provides Dividend Guidance for the Full Year Ending December 31, 2023